$ORGO
2025—fueled by game-changing acquisition in regen med!
Boosts market share, innovation pipeline, and Q4 EPS beat (4¢ vs 2¢ exp).
Revenue hit $126M, proving resilience. Don't sleep on this turnaround story!
#StockSurge #ORGO
Nov 7, 2025 · 2:53 PM UTC


